In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 214045-84-8, name is 6-Fluoro-3,4-dihydroisoquinolin-1(2H)-one, introducing its new discovery. Application In Synthesis of 6-Fluoro-3,4-dihydroisoquinolin-1(2H)-one
17alpha-HYDROXYLASE/C17,20 -LYASE INHIBITORS
The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1 , R2 , R3 , R4 , Rs, R6 , A and n are as defined herein. A deuteriated derivative of the compound of Formula (I) is also provided.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 214045-84-8, and how the biochemistry of the body works.Application In Synthesis of 6-Fluoro-3,4-dihydroisoquinolin-1(2H)-one
Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem